Page last updated: 2024-08-21
alpha-aminopyridine and Deep Vein Thrombosis
alpha-aminopyridine has been researched along with Deep Vein Thrombosis in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Adler, M; Arnaiz, DO; Cheeseman, S; Chou, YL; Dole, WP; Ewing, J; Fitch, R; Griedel, BD; Karanjawala, R; Kochanny, MJ; Lee, W; Lentz, D; Liang, A; Light, D; Morrissey, MM; Morser, J; Post, J; Rumennik, G; Sacchi, KL; Sakata, ST; Shaw, KJ; Subramanyam, B; Sullivan, ME; Vergona, R; Walters, J; Wang, YX; White, KA; Whitlow, M; Wu, SC; Ye, B; Zhao, Z | 1 |
Other Studies
1 other study(ies) available for alpha-aminopyridine and Deep Vein Thrombosis
| Article | Year |
|---|---|
Thiophene-anthranilamides as highly potent and orally available factor Xa inhibitors.
Topics: Amides; Aminopyridines; Animals; Anticoagulants; Crystallography, X-Ray; Dogs; Factor Xa Inhibitors; Humans; In Vitro Techniques; Male; Models, Molecular; ortho-Aminobenzoates; Prothrombin Time; Rats; Rats, Wistar; Structure-Activity Relationship; Thiophenes; Venous Thrombosis | 2007 |